Type of Cancer
Multiple Myeloma
Phase
Division (Location)
Study ID
NCT#
Brief Description
A Phase 2b, Open-Label, Single-Arm Study of Selinexor (KPT-330) plus Low-Dose Dexamethasone in Patients with Multiple Myeloma Quad-refractory to Previous Therapies Study Name: STORM (Selinexor Treatment of Refractory Myeloma)
To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.